<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37283920</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Viable SARS-CoV-2 Omicron sub-variants isolated from autopsy tissues.</ArticleTitle><Pagination><StartPage>1192832</StartPage><MedlinePgn>1192832</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1192832</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2023.1192832</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Pulmonary and extrapulmonary manifestations have been described after infection with SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19). The virus is known to persist in multiple organs due to its tropism for several tissues. However, previous reports were unable to provide definitive information about whether the virus is viable and transmissible. It has been hypothesized that the persisting reservoirs of SARS-CoV-2 in tissues could be one of the multiple potentially overlapping causes of long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In the present study, we investigated autopsy materials obtained from 21 cadaveric donors with documented first infection or reinfection at the time of death. The cases studied included recipients of different formulations of COVID-19 vaccines. The aim was to find the presence of SARS-CoV-2 in the lungs, heart, liver, kidneys, and intestines. We used two technical approaches: the detection and quantification of viral genomic RNA using RT-qPCR, and virus infectivity using permissive <i>in vitro</i> Vero E6 culture.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">All tissues analyzed showed the presence of SARS-CoV-2 genomic RNA but at dissimilar levels ranging from 1.01&#x2009;&#xd7;&#x2009;10<sup>2</sup> copies/mL to 1.14&#x2009;&#xd7;&#x2009;10<sup>8</sup> copies/mL, even among those cases who had been COVID-19 vaccinated. Importantly, different amounts of replication-competent virus were detected in the culture media from the studied tissues. The highest viral load were measured in the lung (&#x2248;1.4&#x2009;&#xd7;&#x2009;10<sup>6</sup> copies/mL) and heart (&#x2248;1.9&#x2009;&#xd7;&#x2009;10<sup>6</sup> copies/mL) samples. Additionally, based on partial Spike gene sequences, SARS-CoV-2 characterization revealed the presence of multiple Omicron sub-variants exhibiting a high level of nucleotide and amino acid identity among them.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">These findings highlight that SARS-CoV-2 can spread to multiple tissue locations such as the lungs, heart, liver, kidneys, and intestines, both after primary infection and after reinfections with the Omicron variant, contributing to extending knowledge about the pathogenesis of acute infection and understanding the sequelae of clinical manifestations that are observed during post-acute COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Maffia-Bizzozero, Cevallos, Remes Lenicov, Freiberger, Lopez, Guano Toaquiza, Sviercz, Jarmoluk, Bustos, D&#x2019;Addario, Quarleri and Delpino.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maffia-Bizzozero</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Morgue Judicial de la Naci&#xf3;n, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cevallos</LastName><ForeName>Cintia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenicov</LastName><ForeName>Federico Remes</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freiberger</LastName><ForeName>Rosa Nicole</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Cinthya Alicia Marcela</ForeName><Initials>CAM</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guano Toaquiza</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sviercz</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarmoluk</LastName><ForeName>Patricio</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bustos</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Morgue Judicial de la Naci&#xf3;n, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Addario</LastName><ForeName>Adriana Claudia</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Morgue Judicial de la Naci&#xf3;n, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quarleri</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delpino</LastName><ForeName>M Victoria</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones Biom&#xe9;dicas en Retrovirus y Sida (INBIRS), Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vero E6 cell line</Keyword><Keyword MajorTopicYN="N">omicron variants</Keyword><Keyword MajorTopicYN="N">postmortem tissue</Keyword><Keyword MajorTopicYN="N">virus isolation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>9</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37283920</ArticleId><ArticleId IdType="pmc">PMC10240073</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2023.1192832</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28, 1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandersen S., Chamings A., Bhatta T. R. (2020). SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication. Nat. Commun. 11:6059. doi: 10.1038/s41467-020-19883-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19883-7</ArticleId><ArticleId IdType="pmc">PMC7695715</ArticleId><ArticleId IdType="pubmed">33247099</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquila I., Ricci P., Bonetta C. F., Sacco M. A., Longhini F., Torti C., et al. . (2021). Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff. Med. Leg. J. 89, 40&#x2013;53. doi: 10.1177/0025817220980601, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0025817220980601</ArticleId><ArticleId IdType="pubmed">33475037</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltempo P., Curti S. M., Maserati R., Gherardi M., Castelli M. (2021). Persistence of SARS-CoV-2 RNA in post-mortem swab 35 days after death: a case report. Forensic Sci. Int. 319:110653. doi: 10.1016/j.forsciint.2020.110653, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.forsciint.2020.110653</ArticleId><ArticleId IdType="pmc">PMC7725267</ArticleId><ArticleId IdType="pubmed">33360242</ArticleId></ArticleIdList></Reference><Reference><Citation>Berno G., Fabeni L., Matusali G., Gruber C. E. M., Rueca M., Giombini E., et al. . (2022). SARS-CoV-2 variants identification: overview of molecular existing methods. Pathogens 11:1058. doi: 10.3390/pathogens11091058, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11091058</ArticleId><ArticleId IdType="pmc">PMC9504725</ArticleId><ArticleId IdType="pubmed">36145490</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer D. K., Forero A. (2022). Mechanisms of antiviral immune evasion of SARS-CoV-2. J. Mol. Biol. 434:167265. doi: 10.1016/j.jmb.2021.167265, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.167265</ArticleId><ArticleId IdType="pmc">PMC8457632</ArticleId><ArticleId IdType="pubmed">34562466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. (2022). Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 28, 2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Casagrande M., Fitzek A., Puschel K., Aleshcheva G., Schultheiss H. P., Berneking L., et al. . (2020). Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul. Immunol. Inflamm. 28, 721&#x2013;725. doi: 10.1080/09273948.2020.1770301, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2020.1770301</ArticleId><ArticleId IdType="pubmed">32469258</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . (2020). Centers for Disease Control and Prevention collection and submission of postmortem specimens from deceased persons with known or Supected COVID-19, march 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-postmortem-specimens.html (Accessed December 23, 2020).</Citation></Reference><Reference><Citation>Chen Y., Gu S., Chen Y., Lu H., Shi D., Guo J., et al. . (2022). Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut 71, 222&#x2013;225. doi: 10.1136/gutjnl-2021-324090, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C. C. L., Goh D., Lim X., Tien T. Z., Lim J. C. T., Lee J. N., et al. . (2022). Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 71, 226&#x2013;229. doi: 10.1136/gutjnl-2021-324280, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiani S., Fiorentino M., De Palma A., Foschini M. P., Lazzarotto T., Gabrielli L., et al. . (2021). Pathological post-mortem findings in lungs infected with SARS-CoV-2. J. Pathol. 253, 31&#x2013;40. doi: 10.1002/path.5549</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5549</ArticleId><ArticleId IdType="pubmed">32930394</ArticleId></ArticleIdList></Reference><Reference><Citation>Deinhardt-Emmer S., Wittschieber D., Sanft J., Kleemann S., Elschner S., Haupt K. F., et al. . (2021). Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. elife 10:60361. doi: 10.7554/eLife.60361, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60361</ArticleId><ArticleId IdType="pmc">PMC8009677</ArticleId><ArticleId IdType="pubmed">33781385</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey T. M., Ziegler C. G. K., Heimberg G., Normand R., Yang Y., Segerstolpe A., et al. . (2021). COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107&#x2013;113. doi: 10.1038/s41586-021-03570-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai N., Neyaz A., Szabolcs A., Shih A. R., Chen J. H., Thapar V., et al. . (2020). Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat. Commun. 11:6319. doi: 10.1038/s41467-020-20139-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20139-7</ArticleId><ArticleId IdType="pmc">PMC7725958</ArticleId><ArticleId IdType="pubmed">33298930</ArticleId></ArticleIdList></Reference><Reference><Citation>Edler C., Schroder A. S., Aepfelbacher M., Fitzek A., Heinemann A., Heinrich F., et al. . (2020). Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int. J. Legal Med. 134, 1275&#x2013;1284. doi: 10.1007/s00414-020-02317-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00414-020-02317-w</ArticleId><ArticleId IdType="pmc">PMC7271136</ArticleId><ArticleId IdType="pubmed">32500199</ArticleId></ArticleIdList></Reference><Reference><Citation>Elrobaa I. H., New K. J. (2021). COVID-19: pulmonary and extra pulmonary manifestations. Front. Public Health 9:711616. doi: 10.3389/fpubh.2021.711616, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.711616</ArticleId><ArticleId IdType="pmc">PMC8505777</ArticleId><ArticleId IdType="pubmed">34650947</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control . (2021). Europe WHORO for methods for the detection and characterisation of SARS-CoV-2 variants&#x2013;first update what is New in this update: Key messages. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Methods-for-the-detection-char-SARS-CoV-2-variants_2nd%20update_final.pdf (Accessed August 25, 2022).</Citation></Reference><Reference><Citation>Fitzek A., Schadler J., Dietz E., Ron A., Gerling M., Kammal A. L., et al. . (2021). Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases. Sci. Rep. 11:19342. doi: 10.1038/s41598-021-98499-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98499-3</ArticleId><ArticleId IdType="pmc">PMC8481286</ArticleId><ArticleId IdType="pubmed">34588486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. (2022). Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and Meta-analysis. Int. J. Environ. Res. Public Health 19:422. doi: 10.3390/ijerph191912422</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D., Lim J. C. T., Fernaindez S. B., Joseph C. R., Edwards S. G., Neo Z. W., et al. . (2022). Case report: persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front. Immunol. 13:939989. doi: 10.3389/fimmu.2022.939989, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.939989</ArticleId><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassi S., Arena V., Cattani P., Dell'aquila M., Liotti F. M., Sanguinetti M., et al. . (2022). SARS-CoV-2 viral load and replication in postmortem examinations. Int. J. Legal Med. 136, 935&#x2013;939. doi: 10.1007/s00414-021-02753-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00414-021-02753-2</ArticleId><ArticleId IdType="pmc">PMC8784985</ArticleId><ArticleId IdType="pubmed">35072749</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin D. E. (2022). Why does viral RNA sometimes persist after recovery from acute infections? PLoS Biol. 20:e3001687. doi: 10.1371/journal.pbio.3001687, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001687</ArticleId><ArticleId IdType="pmc">PMC9191737</ArticleId><ArticleId IdType="pubmed">35648781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kute V. B., Fleetwood V. A., Meshram H. S., Guenette A., Lentine K. L. (2021). Use of organs from SARS-CoV-2 infected donors: is it safe? A contemporary review. Curr. Transplant. Rep. 8, 281&#x2013;292. doi: 10.1007/s40472-021-00343-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40472-021-00343-0</ArticleId><ArticleId IdType="pmc">PMC8546195</ArticleId><ArticleId IdType="pubmed">34722116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M. M., Beumer J., Van Der Vaart J., Knoops K., Puschhof J., Breugem T. I., et al. . (2020). SARS-CoV-2 productively infects human gut enterocytes. Science 369, 50&#x2013;54. doi: 10.1126/science.abc1669, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Layne S. P., Walters K. A., Kash J. C., Taubenberger J. K. (2022). More autopsy studies are needed to understand the pathogenesis of severe COVID-19. Nat. Med. 28, 427&#x2013;428. doi: 10.1038/s41591-022-01684-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01684-8</ArticleId><ArticleId IdType="pmc">PMC8940687</ArticleId><ArticleId IdType="pubmed">35177863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. Y., Wing P. A. C., Gala D. S., Noerenberg M., Jarvelin A. I., Titlow J., et al. . (2022). Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences. elife 11:74153. doi: 10.7554/eLife.74153, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.74153</ArticleId><ArticleId IdType="pmc">PMC8776252</ArticleId><ArticleId IdType="pubmed">35049501</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A., Manetti A. C., La Russa R., Di Paolo M., Turillazzi E., Frati P., et al. . (2021). Autopsy findings in COVID-19-related deaths: a literature review. Forensic Sci. Med. Pathol. 17, 279&#x2013;296. doi: 10.1007/s12024-020-00310-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12024-020-00310-8</ArticleId><ArticleId IdType="pmc">PMC7538370</ArticleId><ArticleId IdType="pubmed">33026628</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Cardona A., Lloreta Trull J., Albero-Gonzalez R., Paraira Beser M., Andujar X., Ruiz-Ramirez P., et al. . (2021). SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: two case reports. BMC Gastroenterol. 21:334. doi: 10.1186/s12876-021-01905-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-021-01905-3</ArticleId><ArticleId IdType="pmc">PMC8390036</ArticleId><ArticleId IdType="pubmed">34445965</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M. V., Mcgroder C., Stevens J. S., et al. . (2021). Post-acute COVID-19 syndrome. Nat. Med. 27, 601&#x2013;615. doi: 10.1038/s41591-021-01283-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento T., do Valle Costa L., Ruiz A. D., Ledo C. B., Fernandes V. P. L., Cardoso L. F., et al. . (2023). Vaccination status and long COVID symptoms in patients discharged from hospital. Sci. Rep. 13:2481. doi: 10.1038/s41598-023-28839-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-28839-y</ArticleId><ArticleId IdType="pmc">PMC9922040</ArticleId><ArticleId IdType="pubmed">36774419</ArticleId></ArticleIdList></Reference><Reference><Citation>Nei M. K. S. (2000). Molecular evolution and Phylogenetics Oxford University Press, New York. 3.</Citation></Reference><Reference><Citation>Neurath M. F., Uberla K., Ng S. C. (2021). Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19. Gut 70, 1605&#x2013;1608. doi: 10.1136/gutjnl-2021-324622, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324622</ArticleId><ArticleId IdType="pubmed">33903146</ArticleId></ArticleIdList></Reference><Reference><Citation>Odilov A., Volkov A., Abdullaev A., Gasanova T., Lipina T., Babichenko I. (2021). COVID-19: multiorgan dissemination of SARS-CoV-2 is driven by pulmonary factors. Viruses 14:39. doi: 10.3390/v14010039, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010039</ArticleId><ArticleId IdType="pmc">PMC8777766</ArticleId><ArticleId IdType="pubmed">35062243</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter R. S., Nieters A., Krausslich H. G., Brockmann S. O., Gopel S., Kindle G., et al. . (2022). Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ 379:e071050. doi: 10.1136/bmj-2022-071050</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Plenzig S., Bojkova D., Held H., Berger A., Holz F., Cinatl J., et al. . (2021a). Infectivity of deceased COVID-19 patients. Int. J. Legal Med. 135, 2055&#x2013;2060. doi: 10.1007/s00414-021-02546-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00414-021-02546-7</ArticleId><ArticleId IdType="pmc">PMC7932833</ArticleId><ArticleId IdType="pubmed">33665704</ArticleId></ArticleIdList></Reference><Reference><Citation>Plenzig S., Holz F., Bojkova D., Kettner M., Cinatl J., Verhoff M. A., et al. . (2021b). Detection and infectivity of SARS-CoV-2 in exhumated corpses. Int. J. Legal Med. 135, 2531&#x2013;2536. doi: 10.1007/s00414-021-02670-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00414-021-02670-4</ArticleId><ArticleId IdType="pmc">PMC8302458</ArticleId><ArticleId IdType="pubmed">34302215</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradenas E., Marfil S., Urrea V., Trigueros V., Pidkova T., Pons-Gr&#xed;fols A., et al. . (2023). Impact of hybrid immunity booster vaccination and omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization. iScience 26:106457. doi: 10.1016/j.isci.2023.106457, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106457</ArticleId><ArticleId IdType="pmc">PMC10027310</ArticleId><ArticleId IdType="pubmed">36999095</ArticleId></ArticleIdList></Reference><Reference><Citation>Sablone S., Solarino B., Ferorelli D., Benevento M., Chironna M., Loconsole D., et al. . (2021). Post-mortem persistence of SARS-CoV-2: a preliminary study. Forensic Sci. Med. Pathol. 17, 403&#x2013;410. doi: 10.1007/s12024-021-00375-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12024-021-00375-z</ArticleId><ArticleId IdType="pmc">PMC8105695</ArticleId><ArticleId IdType="pubmed">33963967</ArticleId></ArticleIdList></Reference><Reference><Citation>Saharia K. K., Ramelli S. C., Stein S. R., Roder A. E., Kreitman A., Banakis S., et al. . (2023). Successful lung transplantation using an allograft from a COVID-19-recovered donor: a potential role for subgenomic RNA to guide organ utilization. Am. J. Transplant. 23, 101&#x2013;107. doi: 10.1016/j.ajt.2022.09.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2022.09.001</ArticleId><ArticleId IdType="pmc">PMC9833374</ArticleId><ArticleId IdType="pubmed">36695611</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitou N., Nei M. (1987). The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4, 406&#x2013;425. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">3447015</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A., Marinkovic A., Prakash S., Zhao A., Balendra V., Haider N., et al. . (2022). Post-acute Sequelae in COVID-19 survivors: an overview. SN Compr. Clin. Med. 4:91. doi: 10.1007/s42399-022-01172-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01172-7</ArticleId><ArticleId IdType="pmc">PMC8985741</ArticleId><ArticleId IdType="pubmed">35411333</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder A. S., Edler C., Ondruschka B., Puschel K., Schadler J., Heinemann A., et al. . (2021). The handling of SARS-CoV-2 associated deaths - infectivity of the body. Forensic Sci. Med. Pathol. 17, 411&#x2013;418. doi: 10.1007/s12024-021-00379-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12024-021-00379-9</ArticleId><ArticleId IdType="pmc">PMC8170863</ArticleId><ArticleId IdType="pubmed">34076852</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J. B., Murthy S., Marshall J. C., Relan P., Diaz J. V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition (2022). A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S. R., Ramelli S. C., Grazioli A., Chung J. Y., Singh M., Yinda C. K., et al. . (2022). SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758&#x2013;763. doi: 10.1038/s41586-022-05542-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura K. S. G., Stecher G., Kumar S. (2021). MEGA11: molecular evolutionary genetics analysis version 11. Mol. Biol. Evol. 38, 3022&#x2013;3027. doi: 10.1093/molbev/msab120, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msab120</ArticleId><ArticleId IdType="pmc">PMC8233496</ArticleId><ArticleId IdType="pubmed">33892491</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F., Catalan P., Rodriguez-Grande C., Adan J., Rodriguez-Gonzalez C., Mu&#xf1;oz P., et al. . (2022). Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 22:211. doi: 10.1186/s12879-022-07153-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres C., Nabaes Jodar M., Acu&#xf1;a D., Monta&#xf1;o R. M. Z., Culasso A. C. A., Amadio A. F., et al. . (2023). Omicron waves in Argentina: dynamics of SARS-CoV-2 lineages BA.1, BA.2 and the emerging BA.2.12.1 and BA.4/BA.5. Viruses 15:312. doi: 10.3390/v15020312, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020312</ArticleId><ArticleId IdType="pmc">PMC9965068</ArticleId><ArticleId IdType="pubmed">36851525</ArticleId></ArticleIdList></Reference><Reference><Citation>Trypsteen W., Van Cleemput J., Snippenberg W. V., Gerlo S., Vandekerckhove L. (2020). On the whereabouts of SARS-CoV-2 in the human body: a systematic review. PLoS Pathog. 16:e1009037. doi: 10.1371/journal.ppat.1009037, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009037</ArticleId><ArticleId IdType="pmc">PMC7679000</ArticleId><ArticleId IdType="pubmed">33125439</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zelm M. C. (2022). Immune memory to SARS-CoV-2 omicron BA.1 breakthrough infections: to change the vaccine or not? Sci. Immunol. 7:eabq5901. doi: 10.1126/sciimmunol.abq5901, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abq5901</ArticleId><ArticleId IdType="pubmed">35653497</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J. L., Taccone F. S. (2020). Understanding pathways to death in patients with COVID-19. Lancet Respir. Med. 8, 430&#x2013;432. doi: 10.1016/S2213-2600(20)30165-X, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30165-X</ArticleId><ArticleId IdType="pmc">PMC7270480</ArticleId><ArticleId IdType="pubmed">32272081</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfel R., Corman V. M., Guggemos W., Seilmaier M., Zange S., Muller M. A., et al. . (2020). Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465&#x2013;469. doi: 10.1038/s41586-020-2196-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2196-x</ArticleId><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . (2021). WHO genomic sequencing of SARS-CoV-2 p. 94. Available at: https://www.who.int/publications/i/item/9789240018440 (Accessed July 27, 2022).</Citation></Reference><Reference><Citation>World Health Organization . (2022). End-to-end integration of SARS-CoV-2 and influenza sentinel surveillance: Revised interim guidance, 31 January 2022. Available at: https://apps.who.int/iris/handle/10665/351409 (Accessed 31 January 2022).</Citation></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., Rossler A., et al. . (2022). Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology 163:e498, 495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>